MedPath

Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total hip arthroplasty: randomized controlled trial

Not Applicable
Conditions
Osteoarthritis of the hip, Avascular necrosis of the femoral head, Rheumatoid arthritis
Registration Number
JPRN-UMIN000029797
Lead Sponsor
Hokusuikai Kinen Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Known allergic reaction to tranexamic acid Refusal of blood products

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The volume of perioperative blood loss measured using the calculated blood volume and change in hemoglobin from preoperative to postoperative day 4.
Secondary Outcome Measures
NameTimeMethod
Complication
© Copyright 2025. All Rights Reserved by MedPath